June 29, 2022

tmobilebusiness

Simple Impartial Business

WeissLaw LLP Reminds CCR, TCO, UROV, and PTI Shareholders About Its Ongoing Investigations

NEW YORK, Nov. 30, 2020 /PRNewswire/ —

If you have shares in any of the firms mentioned over and
would like to go over our investigations or have any questions regarding
this discover or your legal rights or passions, be sure to contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Flooring
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

CONSOL Coal Methods LP (NYSE: CCR)&#13

WeissLaw LLP is investigating attainable breaches of the limited partnership agreement, fiduciary duty and other violations of law by the board of directors of CONSOL Coal Assets LP (NYSE: CCR) in link with the proposed acquisition of CCR by CONSOL Vitality Inc. (“CEIX”).  Under the phrases of the agreement, CCR unitholders will get .73 shares of CEIX for just about every CCR unit they have, representing implied for every-share merger consideration of $4.15, dependent upon CEIX’s November 27, 2020 closing rate of $5.68.  If you have CCR models and wish to discuss this investigation or your rights, be sure to call us at 1 of the quantities detailed above or visit our website: https://weisslawllp.com/ccr/  

Taubman Facilities, Inc. (NYSE: TCO)

WeissLaw LLP is investigating possible breaches of fiduciary responsibility and other violations of legislation by the board of administrators of Taubman Facilities, Inc. (NYSE: TCO) in relationship with the revised acquisition of the organization by Simon Property Team, Inc.  Beneath the phrases of the revised settlement, shareholders will receive only $43.00 for every single share of TCO they personal, representing a sizeable reduction from the $52.50 per share that the parties had initially agreed to in February 2020.  If you personal TCO shares and want to focus on this investigation or your legal rights, you should get in touch with us at a single of the figures detailed previously mentioned or take a look at our web-site: https://www.weisslawllp.com/tco/

Urovant Sciences Ltd. (NASDAQ: UROV)

WeissLaw LLP is investigating feasible breaches of fiduciary obligation and other violations of law by the board of administrators of Urovant Sciences Ltd. (NASDAQ: UROV) in connection with the proposed interested-get together acquisition of the corporation by Sumitovant Biopharma Ltd., UROV’s the vast majority shareholder that at present owns 72{0fd7e6f75ade3d5ae67778d77dd996bcc8aca117c4e234285c3d1a0079535f7c} of the company’s exceptional widespread shares.  Less than the terms of the acquisition agreement, the company’s shareholders will obtain only $16.25 in dollars for each share of UROV typical stock that they possess.   If you own UROV shares and would like to examine this investigation or your rights, make sure you contact us at a person of the numbers stated previously mentioned or pay a visit to our internet site: https://www.weisslawllp.com/urov/  &#13

Proteostasis Therapeutics, Inc. (NASDAQ: PTI)

WeissLaw LLP is investigating feasible breaches of fiduciary obligation and other violations of regulation by the board of administrators of Proteostasis Therapeutics, Inc. (NASDAQ: PTI) in connection with the company’s proposed merger with Yumanity Therapeutics, Inc. (“Yumanity”).  Less than the conditions of the arrangement, PTI will receive all remarkable shares of Yumanity in trade for recently-issued shares of PTI prevalent inventory, with current PTI shareholders possessing only 32.5{0fd7e6f75ade3d5ae67778d77dd996bcc8aca117c4e234285c3d1a0079535f7c} of the new entity.  If you very own PTI shares and would like to examine this investigation or your legal rights, make sure you contact us at 1 of the numbers stated earlier mentioned or stop by our website: https://weisslawllp.com/proteostasis-therapeutics-inc/

Cision View unique material to download multimedia:https://www.prnewswire.com/information-releases/weisslaw-llp-reminds-ccr-tco-urov-and-pti-shareholders-about-its-ongoing-investigations-301181986.html

Source WeissLaw LLP